Revenue | ₹1,247.97Cr |
Net Profits | ₹127.53Cr |
Net Profit Margins | 10.22% |
Strides Pharma Science Ltd’s revenue jumped 4.4% since last year same period to ₹1,247.97Cr in the Q2 2025-2026. On a quarterly growth basis, Strides Pharma Science Ltd has generated 10.59% jump in its revenue since last 3-months.
Strides Pharma Science Ltd’s net profit jumped 77.52% since last year same period to ₹127.53Cr in the Q2 2025-2026. On a quarterly growth basis, Strides Pharma Science Ltd has generated 28.03% jump in its net profits since last 3-months.
Strides Pharma Science Ltd’s net profit margin jumped 70.03% since last year same period to 10.22% in the Q2 2025-2026. On a quarterly growth basis, Strides Pharma Science Ltd has generated 15.76% jumped in its net profit margins since last 3-months.
The revenue for Strides Pharma Science Ltd in the Q2 results 2025 was ₹1,247.97Cr.
The net profit for Strides Pharma Science Ltd in the Q2 results 2025 was ₹127.53Cr.
The net profit margin for Strides Pharma Science Ltd in the Q2 results 2025 was 10.22%.
The revenue for Strides Pharma Science Ltd in the Q2 results 2024 was ₹1,195.35Cr.
The net profit for Strides Pharma Science Ltd in the Q2 results 2024 was ₹71.84Cr.
The net profit margin for Strides Pharma Science Ltd in the Q2 results 2024 was 6.01%.